The Wellcome Trust website reports that the Stevenage Bioscience Catalyst (SBC) is the UK’s first open innovation bioscience campus, due to open at the beginning of next year. They have already started conversations with their stakeholders on how open innovation between them will work in real life. Given the long and risky timelines that are inherent in drug discovery and development, they don’t expect open innovation to be generating quick returns. However, the value it has added in consumer healthcare and other sectors makes them confident the same will happen in this area as well.
To read the full, original article click on this link: Is Your Mind Closed to Open Innovation? :: Open Innovation Community
